188 related articles for article (PubMed ID: 11228062)
41. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
42. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.
Fulghesu AM; Ciampelli M; Belosi C; Apa R; Pavone V; Lanzone A
Fertil Steril; 2001 Aug; 76(2):326-31. PubMed ID: 11476780
[TBL] [Abstract][Full Text] [Related]
43. Two- and three-dimensional sonographic and color Doppler techniques for diagnosis of polycystic ovary syndrome. The stromal/ovarian volume ratio as a new diagnostic criterion.
Battaglia C; Battaglia B; Morotti E; Paradisi R; Zanetti I; Meriggiola MC; Venturoli S
J Ultrasound Med; 2012 Jul; 31(7):1015-24. PubMed ID: 22733850
[TBL] [Abstract][Full Text] [Related]
44. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
45. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
Schachter M; Balen AH; Patel A; Jacobs HS
Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
[TBL] [Abstract][Full Text] [Related]
46. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.
van Santbrink EJ; Hop WC; Fauser BC
Fertil Steril; 1997 Mar; 67(3):452-8. PubMed ID: 9091329
[TBL] [Abstract][Full Text] [Related]
47. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.
Balen AH; Conway GS; Kaltsas G; Techatrasak K; Manning PJ; West C; Jacobs HS
Hum Reprod; 1995 Aug; 10(8):2107-11. PubMed ID: 8567849
[TBL] [Abstract][Full Text] [Related]
48. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
49. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
[TBL] [Abstract][Full Text] [Related]
50. Ovarian stromal echogenicity in women with normal and polycystic ovaries.
Buckett WM; Bouzayen R; Watkin KL; Tulandi T; Tan SL
Hum Reprod; 1999 Mar; 14(3):618-21. PubMed ID: 10221685
[TBL] [Abstract][Full Text] [Related]
51. [Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].
He LR; Zhou LX; Pan RK; Zhang X
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):350-4. PubMed ID: 21733371
[TBL] [Abstract][Full Text] [Related]
52. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
53. Relationship between early follicular serum estrone level and other hormonal or ultrasonographic parameters in women with polycystic ovary syndrome.
Chun S
Gynecol Endocrinol; 2020 Feb; 36(2):143-147. PubMed ID: 31242783
[TBL] [Abstract][Full Text] [Related]
54. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
[TBL] [Abstract][Full Text] [Related]
55. Isolated premature pubarche: ultrasonographic and color Doppler analysis--a longitudinal study.
Battaglia C; Regnani G; Mancini F; Iughetti L; Bernasconi S; Volpe A; Flamigni C; Venturoli S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3148-54. PubMed ID: 12107215
[TBL] [Abstract][Full Text] [Related]
56. The pattern of changes in ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle.
Engmann L; Sladkevicius P; Agrawal R; Bekir J; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):26-33. PubMed ID: 10201083
[TBL] [Abstract][Full Text] [Related]
57. Three-dimensional power Doppler imaging in the diagnosis of polycystic ovary syndrome.
Mala YM; Ghosh SB; Tripathi R
Int J Gynaecol Obstet; 2009 Apr; 105(1):36-8. PubMed ID: 19201404
[TBL] [Abstract][Full Text] [Related]
58. Doppler parameters of uterine and ovarian stromal blood flow in women with polycystic ovary syndrome and normally ovulating women undergoing controlled ovarian stimulation.
Pinkas H; Mashiach R; Rabinerson D; Avrech OM; Royburt M; Rufas O; Meizner I; Ben-Rafael Z; Fisch B
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):197-200. PubMed ID: 9793192
[TBL] [Abstract][Full Text] [Related]
59. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.
Järvelä IY; Mason HD; Sladkevicius P; Kelly S; Ojha K; Campbell S; Nargund G
J Assist Reprod Genet; 2002 Dec; 19(12):582-90. PubMed ID: 12503891
[TBL] [Abstract][Full Text] [Related]
60. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
